Regulatory Updates
Sep 7, 2026•1 min read
Korean Pharma & Bio Leaders Call for Next‑Gen Modalities, AI Integration and Regulatory Reform
At CPHI Korea 2026, experts urged Korean pharma and biotech firms to secure next‑generation modalities, fuse physical AI, and expedite preclinical and data legislation updates.
Regulatory Updates
Sep 7, 2026•1 min read
Pharmacy Students Urge Caution on Expanding Drug Delivery Services
Pharmacy students stress that expanding medication delivery must consider pharmacists' role and risk of misuse, warning against unchecked growth.
Regulatory Updates
Sep 7, 2026•1 min read
Korean Parliament Passes Pharmacy Naming Restriction Law
The National Assembly approved the 'Pharmacy Naming Restriction Law' aimed at preventing misleading pharmacy titles that could treat medicines as consumer goods.
1
Regulatory Updates
Sep 7, 2026•1 min read
Government to Discuss Expanding Telemedicine Medication Delivery; Issue Expected in National Audit
The government plans to discuss expanding medication delivery linked to telemedicine, and the topic may be raised during this year’s National Assembly audit, prompting potential regulatory scrutiny.
Regulatory Updates
Sep 7, 2026•1 min read
National Bio Innovation Committee Urges Integrated Regulatory and Investment Reform at CPHI Korea 2026
At CPHI Korea 2026, committee member Seo Kyung‑won urged Korea to abandon fragmented ministries and redesign its regulatory and investment ecosystem to become a global bio‑health leader.
Regulatory Updates
Sep 7, 2026•1 min read
Health NGOs Oppose Government Plan to Expand Remote Prescription Drug Delivery to All Patients
Around 40 health‑care civil society groups have jointly issued a statement opposing the government's proposal to extend remote prescription drug delivery to all patients, citing concerns over patient safety and market influence of telemedicine platforms.
Regulatory Updates
Sep 7, 2026•1 min read
Health NGOs Oppose Expansion of Telemedicine Prescription Delivery to All Patients
South Korean health‑civil society groups have formally opposed the government’s plan to extend telemedicine prescription delivery to all patients, citing patient safety and health‑insurance cost concerns.
Regulatory Updates
Sep 6, 2026•1 min read
Chungbuk Pharmacists and Students Protest for Clear Han‑Yak‑Sa Licensing
Pharmacists and pharmacy students from Chungbuk joined a relay protest at the presidential office, demanding the government clarify licensing scopes for pharmacists and han‑yak‑sa and resolve longstanding issues.
Regulatory Updates
Sep 6, 2026•1 min read
KPA Vows Strong Opposition to Gov't Full Prescription Drug Delivery Expansion
The Korean Pharmaceutical Association announced it will mount legislative and policy resistance to the government's plan to expand prescription drug delivery to all telemedicine patients, refusing to join related government talks.
Regulatory Updates
Sep 6, 2026•1 min read
South Korean Health NGOs Criticize Government's Telemedicine Drug Delivery Expansion
Civil society health groups in South Korea denounced the Lee Jae‑myung administration’s plan to fully expand telemedicine drug delivery, urging investment in public medical infrastructure instead.
Regulatory Updates
Sep 6, 2026•1 min read
HuBase Hosts 2026 Pharmacy Opening Symposium on Risk Management in Seoul
HuBase co‑hosted a symposium in Seoul on May 23, offering practical criteria to assess pharmacy property values and contracts amid growing market complexity.
Regulatory Updates
Sep 6, 2026•1 min read
Korea to expand telemedicine prescription delivery, faces hurdles
The Korean government proposes broader prescription delivery for telemedicine patients, but experts question the evidence and note needed legal changes.